Genomma Lab Internacional Declares Its Twelfth Dividend Payment to Shareholders
Genomma Lab Internacional Declares Twelfth Dividend Payment
On June 23, 2025, Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB), a significant player in the pharmaceutical and personal care sector in Mexico, revealed its twelfth cash dividend distribution. This announcement details a cash dividend of 0.20 Mexican pesos per share, totaling 200 million pesos for shareholders recorded as of July 1, 2025.
Genomma Lab has been navigating its growth trajectory in both local and international markets, establishing itself as a formidable competitor among pharmaceutical companies. The recent declaration of the dividend comes as a result of the Board of Directors' decision, empowered by the Annual General Shareholders Meeting that took place on April 24, 2025.
Financial Commitment and Future Outlook
Genomma Lab’s ongoing commitment to its shareholders is notable. The company intends to maintain a quarterly dividend payment schedule, reflecting its robust financial health and commitment to returning value to its stockholders. The shares are listed on the Bolsa Mexicana de Valores (Mexican Stock Exchange) under the ticker
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.